EGFR-targeted immunoliposomes as a selective delivery system of simvastatin, with potential use in treatment of triple-negative breast cancers.
Int J Pharm
; 569: 118605, 2019 Oct 05.
Article
in En
| MEDLINE
| ID: mdl-31400433
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Simvastatin
/
Triple Negative Breast Neoplasms
/
Cetuximab
/
Antineoplastic Agents, Immunological
/
Mammary Neoplasms, Experimental
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Int J Pharm
Year:
2019
Document type:
Article
Affiliation country:
Poland
Country of publication:
Netherlands